Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation

Walker, S.; Groom, G.; Davis, R.H.; Hibbard, B.M.; Griffiths, K.

Lancet 2(7940): 842-844

1975


ISSN/ISBN: 0140-6736
PMID: 53330
Document Number: 93310
2-Bromo- alpha -ergocryptine (bromocriptine) in a dosage of 2.5 mg twice daily caused a rapid fall in plasma prolactin. It was more effective than either a single dose of 4 mg quinoestrol or a placebo in suppressing puerperal lactation, as judged by milk flow and the relief of breast pain and congestion. Patients who received quinoestrol were more comfortable than those who received placebo.

Document emailed within 1 workday
Secure & encrypted payments